Abstract:Objective:To study the tolerance of Yanshen oral solution and to determine its safe dosage.Methods:A total of 38 healthy volunteers(aged 18-32 years) entered the tolerance study and received a single-dose regimen or a multi-dose regimen in clinical trials.The single-dose regimen was an open study,26 subjects were divided into 5 groups:the 5 ml dose group(n=4),the 10 ml dose group(n=4),the 20 ml dose group(n=6),the 30 ml dose group(n=6),and the 40 ml dose group(n=6).The multiple-dose regimen was a randomized,double-blinded,and placebo-controlled study,12 subjects were divided into 2 groups;the Yanshen group(n=6) and the placebo group(n=6).The ratio of male to female in each group was 1 to 1.During the study period, the subjects' vital signs and adverse events were observed and recorded;routine blood,urine,and stool tests,blood biochemical tests (including the levels of K~+,Na~+,Ca~(2+),Cl~-,glutamic-pyruvic transaminase,aspartate aminotransferase,total bilirubin,alkaline phosphatase,urea nitrogen,creatinine,etc.),and electrocardiogram(ECG) were performed and all the results were statistically analyzed.Results:There were no differences in the age,gender,body weight and height among the 4 single-dose groups(the 40 ml dose group was canceled because of intolerance) and between the 2 multiple-dose groups.The maximum tolerance dose was 30 ml in the single-dose regimen and 20 subjects completed the study.A dose of 20 ml thrice daily for 7 consecutive days was selected for the multiple-dose regimen study.There were no statistically significant changes in vital signs,the routine blood,urine,and stool tests, and blood biochemical tests in all subjects after receiving the single-dose or multiple dose regimens.In the single-dose regimen study, sinus bradycardia occurred in 1 subject each in the 20 ml dose and 30 ml dose groups.All subjects receiving the multi-dose regimen had normal ECG.The main adverse reactions after drug administration were mild nausea and vomiting.In the single-dose regimen study,nausea occurred in 1 subject in the 5 ml dose group and 3 subjects in the 20 ml dose group,vomiting occurred in 1 subject in the 5 ml dose group and 2 subjects in the 20 ml dose group;in addition,all 6 subjects in the 30 ml dose group developed nausea and vomiting.In the multiple-dose regimen study,mild nausea and vomiting occurred in 2 subjects in the Yanshen group;however,the symptoms improved 30 min after developing adverse reactions.Conclusion:Yanshen oral solution could be well tolerated in a dose of 20 ml thrice daily with no severe adverse reactions.

Tolerance of Octohydroaminoacridine Succinate Tablets after Single Dose Administration in Chinese Healthy Volunteers

Tolerance of soxifloxacin hydrochloride tablet after ascending single dose in Chinese healthy subjects

P4-308: Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild to moderate Alzheimer's disease: A phase ii multicenter randomized controlled trial

Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild-to-moderate Alzheimer's disease: a Phase II multicenter randomised controlled trial.

A Single-Center, Randomized, Open-Label, Dose-Escalation Study to Evaluate the Pharmacokinetics of Tacrine Analogue Octahydrogenacridine Succinate Tablets in Healthy Chinese Subjects

Pharmacokinetics and Safety of Pitavastatin Calcium Tablets in Chinese Healthy Volunteers after a Single Oral Dose Administration

Tolerability Trial of Peramivir Trihydrate and Sodium Chloride Injection in Healthy Volunteers

Tolerance of antofloxacin hydrochloride tablet after high single oral dose in Chinese healthy subjects

Tolerance and Safety of Buagafuran in Chinese Healthy Volunteers

Tolerance of Antofloxacin Hydrochloride after Ascending Single Oral Dose Administration in Healthy Male Volunteers

Study on tolerance of Yanshen oral solution in phase Ⅰ clinical trials

Tolerance study of ulinastatin injection in Chinese healthy volunteers

A Phase I Study for Evaluating the Safety and Tolerability of Zhishenjieyu Capsule

Tolerability and Pharmacokinetics of Tratinterol Hydrochloride Tablets in Healthy Subjects after a Single Dose Administration

A phase Ⅰ trial for the tolerability of Aoshaen injection

PhaseⅠSafety and Tolerability Study of Multiple Oral Dosing D-polymannuronicate Tablets in Healthy Volunteers

Toleration of vardenafil tablets in healthy volunteers after a single oral administration

Tolerance of Bajitian oligosaccharide capsule in Chinese healthy volunteers

Pharmacokinetic Study of Frovatriptan Succinate Tablet after Single and Multiple Oral Doses in Chinese Healthy Subjects

Pharmacokinetics of Dapoxetine Hydrochloride in Chinese Healthy Male Volunteers

The Safety and Tolerance of Herbal Anti-Angina Drug Compound Danshen Droplet Pill in Healthy Volunteers